Affiliation
Centre for Occupational and Environmental Health, University of Manchester, United Kingdom. a.povey@manchester.ac.ukIssue Date
2007-08-01
Metadata
Show full item recordAbstract
O(6)-Alkylguanine-DNA alkyltransferase (MGMT) repairs DNA adducts that result from alkylation at the O(6) position of guanine. These lesions are mutagenic and toxic and can be produced by a variety of agents including the tobacco-specific nitrosamines, carcinogens present in cigarette smoke. Here, we review some of our work in the context of inter-individual differences in MGMT expression and their potential influence on lung cancer risk. In humans there are marked inter-individual differences in not only levels of DNA damage in the lung (N7-methylguanine) that can arise from exposure to methylating agents but also in MGMT activity in lung tissues. In the presence of such exposure, this variability in MGMT activity may alter cancer susceptibility, particularly as animal models have demonstrated that the complete absence of MGMT activity predisposes to alkylating-agent induced cancer while overexpression is protective. Recent studies have uncovered a series of polymorphisms that affect protein activity or are associated with differences in expression levels. The associations between these (and other) polymorphisms and cancer risk are inconsistent, possibly because of small sample sizes and inter-study differences in lung cancer histology. We have recently analysed a consecutive series of case-control studies and found evidence that lung cancer risk was lower in subjects with the R178 allele.Citation
Lung cancer risk and variation in MGMT activity and sequence. 2007, 6 (8):1134-44 DNA RepairJournal
DNA RepairDOI
10.1016/j.dnarep.2007.03.022PubMed ID
17569600Type
ArticleLanguage
enISSN
1568-7864ae974a485f413a2113503eed53cd6c53
10.1016/j.dnarep.2007.03.022
Scopus Count
Collections
Related articles
- O(6)-methylguanine-DNA methyltransferase (MGMT): impact on cancer risk in response to tobacco smoke.
- Authors: Christmann M, Kaina B
- Issue date: 2012 Aug 1
- MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.
- Authors: Kaina B, Christmann M, Naumann S, Roos WP
- Issue date: 2007 Aug 1
- Development of a new application of the comet assay to assess levels of O6-methylguanine in genomic DNA (CoMeth).
- Authors: Ramos AA, Pedro DF, Lima CF, Collins AR, Pereira-Wilson C
- Issue date: 2013 Jul
- Implication of a Chromosome 15q15.2 Locus in Regulating UBR1 and Predisposing Smokers to MGMT Methylation in Lung.
- Authors: Leng S, Wu G, Collins LB, Thomas CL, Tellez CS, Jauregui AR, Picchi MA, Zhang X, Juri DE, Desai D, Amin SG, Crowell RE, Stidley CA, Liu Y, Swenberg JA, Lin Y, Wathelet MG, Gilliland FD, Belinsky SA
- Issue date: 2015 Aug 1
- Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis.
- Authors: Hu Z, Wang H, Shao M, Jin G, Sun W, Wang Y, Liu H, Wang Y, Ma H, Qian J, Jin L, Wei Q, Lu D, Huang W, Shen H
- Issue date: 2007 May